Famotidine belongs to the class of H₂-receptor antagonists used to reduce excessive stomach acid. In Hong Kong it is available as a prescription pill in strengths of 20 mg and 40 mg. The medication is marketed by several manufacturers and is regulated by the Hong Kong Department of Health under the Medicines and Poisons Ordinance.
Famotidine blocks histamine H₂ receptors located on the parietal cells of the stomach lining. By preventing histamine from binding, the drug reduces the activity of the gastric proton pump, leading to a decrease in the volume and acidity of gastric secretions. The onset of action typically occurs within 30 minutes, with peak effect at about 2 hours, and the acid-suppressing effect can last up to 12 hours. This mechanism helps heal ulcers and relieves symptoms caused by acid reflux.
These indications are approved by major regulatory agencies such as the U.S. FDA and the European EMA, and are recognized by Hong Kong health authorities for the same therapeutic purposes.
Off-label use requires medical supervision and an individualized risk assessment.
Ideal candidates are adults with confirmed acid-related gastrointestinal conditions who have no known hypersensitivity to the drug.
Patients with a history of cardiac arrhythmias should discuss use with their clinician, as high-dose famotidine has been linked, albeit rarely, to QT-interval prolongation.
These effects are usually transient and resolve without specific treatment.
Standard adult dosing
20 mg once daily for mild GERD or ulcer prophylaxis.
40 mg once daily for confirmed ulcer disease.
20 mg twice daily (every 12 hours) may be prescribed for more severe ulcer healing.
Renal adjustment
CrCl 10-30 mL/min: 20 mg once daily.
CrCl < 10 mL/min: 20 mg every 48 hours (under physician supervision).
Administration
Swallow the pill whole with a full glass of water.
No need to crush or chew.
Missed dose
Take the missed dose as soon as remembered if it is at least 6 hours before the next scheduled dose. Otherwise, skip and resume the regular schedule; do not double-dose.
Overdose
Symptoms may include severe drowsiness, flushing, or cardiac arrhythmias. Seek immediate medical attention; standard supportive care is employed.
Discontinuation
Famotidine does not require tapering. Discontinue under medical advice if symptoms persist or adverse reactions develop.
This article provides educational information about famotidine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.